SEC Form 5 · accession 0001140361-15-004484
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Dec 31, 2014
Accepted (ET)
Feb 6, 2015 · 12:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2014 | G | 46 | $0.00 | D | 99,200 | D | |
| Common StockF2 | Nov 5, 2014 | G | 46 | $0.00 | A | 23,935 | I | Shares held by Baffi Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired by the reporting person on October 31, 2014 pursuant to the issuer's Employee Stock Purchase Plan
- F2On November 5, 2014 the reporting person gifted 46 shares of common stock to his family trust. The reporting person is the trustee.